Who
Bob Holmen
Director
Company insider
Files Form 4 as: Director, Sensei Biotherapeutics.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 3 Feb 2021
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | Sensei Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 10 Jul 2023filed 12 Jul 2023 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,550 at $0.00 | filing |
| 10 Jul 2023filed 12 Jul 2023 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Code A | —4,466 at $0.00 | filing |
| 10 Jun 2022filed 14 Jun 2022 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,550 at $0.00 | filing |
| 10 Jun 2022filed 14 Jun 2022 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Code A | —4,466 at $0.00 | filing |
| 3 Feb 2021filed 5 Feb 2021 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,666 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.